Cargando…
LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer
Unlike other types of breast cancer, triple negative breast cancer (TNBC) does not respond to therapies targeting human epidermal growth factor receptor-2 (HER2) or hormone therapy, and the prognosis of patients with TNBC is usually poor. The role of long non-coding RNA (lncRNA) small nucleolar RNA...
Autores principales: | Aini, Shataer, Bolati, Shayiti, Ding, Wei, Liu, Siyin, Su, Pengcheng, Aili, Saiding, Naman, Yimin, Xuekelaiti, Kuerban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275935/ https://www.ncbi.nlm.nih.gov/pubmed/35506202 http://dx.doi.org/10.1080/21655979.2022.2063592 |
Ejemplares similares
-
lncRNA SNHG17 is Downregulated in Gestational Diabetes Mellitus (GDM) and Has Predictive Values
por: Li, Jingjun, et al.
Publicado: (2021) -
MicroRNA-152 Inhibits Cell Proliferation, Migration, and Invasion in Breast Cancer
por: Maimaitiming, Adilijiang, et al.
Publicado: (2020) -
LncRNA SNHG10 is downregulated in non-small cell lung cancer and predicts poor survival
por: Liang, Meng, et al.
Publicado: (2020) -
LncRNA SNHG9 is downregulated in osteoarthritis and inhibits chondrocyte apoptosis by downregulating miR-34a through methylation
por: Zhang, Hongfei, et al.
Publicado: (2020) -
LncRNA SNHG16 contributes to tumor progression via the miR-302b-3p/SLC2A4 axis in pancreatic adenocarcinoma
por: Xu, Hao, et al.
Publicado: (2021)